NCT01556100View on ClinicalTrials.gov

Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2015

Conditions
Parkinson Disease
Interventions
DRUG

18F-DTBZ AV-133

A total 40 PD subjects will be included in this study. PD subjects between 20 and 80 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, and blood test.

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT01556100 - Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression | Biotech Hunter | Biotech Hunter